JRSDX
Price
$11.56
Change
-$0.35 (-2.94%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

JRSDX vs VFINX

Header iconJRSDX vs VFINX Comparison
Open Charts JRSDX vs VFINXBanner chart's image
JH Adaptive Risk Mgd U.S. Eq D
Price$11.56
Change-$0.35 (-2.94%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
JRSDX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JRSDX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRSDX is a Hold and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. JRSDX (637M). VFINX pays higher dividends than JRSDX: VFINX (1.24) vs JRSDX (0.51). JRSDX was incepted earlier than VFINX: JRSDX (10 years) vs VFINX (48 years). JRSDX is a more actively managed with annual turnover of: 313.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than JRSDX: VFINX (0) vs JRSDX (2500). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. JRSDX (25.09). VFINX return over 5 years is better than : 88.65 vs. JRSDX (10.18).
JRSDXVFINXJRSDX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years48 years-
Gain YTD24.06127.27588%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets637M1.37T0%
Annual Yield % from dividends0.511.2441%
Returns for 1 year25.0927.6391%
Returns for 3 years-7.1130.99-23%
Returns for 5 years10.1888.6511%
Returns for 10 yearsN/A193.62-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc